| Dr Justin Daniel Heistand, MD | |
|
11511 Ne 10th St, Bellevue, WA 98004-8578 | |
| (425) 502-4120 | |
| Not Available |
| Full Name | Dr Justin Daniel Heistand |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 11511 Ne 10th St, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598928244 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD 60217230 (Washington) | Secondary |
| 208000000X | Pediatrics | ML60019739 (Washington) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Identification of a specific genetic mutation in patients with non-small-cell lung cancer (NSCLC) helps clinicians select the best treatment option. Potential NSCLC patients usually undergo invasive tissue biopsy, which may often be unnecessary and delays treatment.
Ana Cores, a 54-year old Hackensack resident, worried about how a sudden loss of peripheral vision would impact the quality of her life. After undergoing MRIs, eye exams and many diagnostic tests, Cores opted to visit UMDNJ-The University Hospital where Dr. James K. Liu, a skull base neurosurgeon, and Dr. Jean Anderson Eloy, an otolaryngologist, used a new three- dimensional endoscope to remove a brain tumor through her nose that was pressing on her optic nerve and causing her to go blind.
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, today announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound 131I-TM601 in the treatment of recurrent malignant glioma.
"On Red Nose Day, we are reminded of the famine in Ethiopia that triggered the first Comic Relief, over 25 years ago," and "as we reflect, we now know that the link between malnutrition and infectious disease makes for a particularly vicious circle," Seth Berkley, CEO of the GAVI Alliance, writes in an opinion piece in the Guardian's "Global Development Professionals Network."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Daniel Heistand, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-4120 | Dr Justin Daniel Heistand, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-4120 |
News Archive
Identification of a specific genetic mutation in patients with non-small-cell lung cancer (NSCLC) helps clinicians select the best treatment option. Potential NSCLC patients usually undergo invasive tissue biopsy, which may often be unnecessary and delays treatment.
Ana Cores, a 54-year old Hackensack resident, worried about how a sudden loss of peripheral vision would impact the quality of her life. After undergoing MRIs, eye exams and many diagnostic tests, Cores opted to visit UMDNJ-The University Hospital where Dr. James K. Liu, a skull base neurosurgeon, and Dr. Jean Anderson Eloy, an otolaryngologist, used a new three- dimensional endoscope to remove a brain tumor through her nose that was pressing on her optic nerve and causing her to go blind.
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, today announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound 131I-TM601 in the treatment of recurrent malignant glioma.
"On Red Nose Day, we are reminded of the famine in Ethiopia that triggered the first Comic Relief, over 25 years ago," and "as we reflect, we now know that the link between malnutrition and infectious disease makes for a particularly vicious circle," Seth Berkley, CEO of the GAVI Alliance, writes in an opinion piece in the Guardian's "Global Development Professionals Network."
› Verified 2 days ago
Eric Albert Gustafson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2700 Northup Way, Bellevue, WA 98004 Phone: 425-827-4600 | |
Dr. Arlene Elizabeth Ritzen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1900 116th Ave Ne, Bellevue, WA 98004 Phone: 425-453-0404 | |
Dr. Emily Susan Showman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3633 136th Place Se, Suite #110, Bellevue, WA 98006 Phone: 425-747-7202 Fax: 425-643-0635 | |
Ildiko Hegyvary Thomas, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Bill M Fournarakis, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2700 Northup Way, Bellevue, WA 98004 Phone: 425-827-4600 Fax: 425-828-2256 | |
Irene Hwang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3633 136th Place Se, Suite #110, Bellevue, WA 98006 Phone: 425-747-7202 Fax: 425-643-0635 | |
Pamela Laborde, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3633 136th Place Se, Suite #110, Bellevue, WA 98006 Phone: 425-747-7202 Fax: 425-643-0635 |